These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin. Yoon YK, Kim JY, Park DW, Sohn JW, Kim MJ. J Antimicrob Chemother; 2010 May; 65(5):1015-8. PubMed ID: 20200036 [Abstract] [Full Text] [Related]
9. Area under the concentration-time curve to minimum inhibitory concentration ratio as a predictor of vancomycin treatment outcome in methicillin-resistant Staphylococcus aureus bacteraemia. Jung Y, Song KH, Cho Je, Kim HS, Kim NH, Kim TS, Choe PG, Chung JY, Park WB, Bang JH, Kim ES, Park KU, Park SW, Kim HB, Kim NJ, Oh MD. Int J Antimicrob Agents; 2014 Feb; 43(2):179-83. PubMed ID: 24315788 [Abstract] [Full Text] [Related]
10. Daptomycin versus vancomycin for bloodstream infections due to methicillin-resistant Staphylococcus aureus with a high vancomycin minimum inhibitory concentration: a case-control study. Moore CL, Osaki-Kiyan P, Haque NZ, Perri MB, Donabedian S, Zervos MJ. Clin Infect Dis; 2012 Jan 01; 54(1):51-8. PubMed ID: 22109947 [Abstract] [Full Text] [Related]
11. Site of infection rather than vancomycin MIC predicts vancomycin treatment failure in methicillin-resistant Staphylococcus aureus bacteraemia. Walraven CJ, North MS, Marr-Lyon L, Deming P, Sakoulas G, Mercier RC. J Antimicrob Chemother; 2011 Oct 01; 66(10):2386-92. PubMed ID: 21775337 [Abstract] [Full Text] [Related]
12. Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study. Chang HJ, Hsu PC, Yang CC, Siu LK, Kuo AJ, Chia JH, Wu TL, Huang CT, Lee MH. J Antimicrob Chemother; 2012 Mar 01; 67(3):736-41. PubMed ID: 22169187 [Abstract] [Full Text] [Related]
13. Impact of vancomycin MIC creep on patients with methicillin-resistant Staphylococcus aureus bacteremia. Yeh YC, Yeh KM, Lin TY, Chiu SK, Yang YS, Wang YC, Lin JC. J Microbiol Immunol Infect; 2012 Jun 01; 45(3):214-20. PubMed ID: 22571999 [Abstract] [Full Text] [Related]
14. Method-specific performance of vancomycin MIC susceptibility tests in predicting mortality of patients with methicillin-resistant Staphylococcus aureus bacteraemia. Chen SY, Liao CH, Wang JL, Chiang WC, Lai MS, Chie WC, Chang SC, Hsueh PR. J Antimicrob Chemother; 2014 Jan 01; 69(1):211-8. PubMed ID: 23997017 [Abstract] [Full Text] [Related]
18. Is there a clinical association of vancomycin MIC creep, agr group II locus, and treatment failure in MRSA bacteremia? de Sanctis JT, Swami A, Sawarynski K, Gerasymchuk L, Powell K, Robinson-Dunn B, Carpenter CF, Sims MD. Diagn Mol Pathol; 2011 Sep 01; 20(3):184-8. PubMed ID: 21817905 [Abstract] [Full Text] [Related]
20. Impact of area under the concentration-time curve to minimum inhibitory concentration ratio on vancomycin treatment outcomes in methicillin-resistant Staphylococcus aureus bacteraemia. Song KH, Kim HB, Kim HS, Lee MJ, Jung Y, Kim G, Hwang JH, Kim NH, Kim M, Kim CJ, Choe PG, Chung JY, Park WB, Kim ES, Park KU, Kim NJ, Kim EC, Oh MD. Int J Antimicrob Agents; 2015 Dec 01; 46(6):689-95. PubMed ID: 26555059 [Abstract] [Full Text] [Related] Page: [Next] [New Search]